Early administration of adalimumab for paediatric uveitis due to Behçet’s disease

Overview of attention for article published in Pediatric Rheumatology, June 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 9,707 followers.

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease https://t.co/qYYDmlkExO #fulltext

RT @emma_beltran: Early administration of adalimumab for paediatric uveitis due to Behçet's disease. - PubMed - NCBI https://t.co/GzCK0AdO2N

RT @emma_beltran: Early administration of adalimumab for paediatric uveitis due to Behçet's disease. - PubMed - NCBI https://t.co/GzCK0AdO2N

RT @emma_beltran: Early administration of adalimumab for paediatric uveitis due to Behçet's disease. - PubMed - NCBI https://t.co/GzCK0AdO2N

Early administration of adalimumab for paediatric uveitis due to Behçet's disease. - PubMed - NCBI https://t.co/GzCK0AdO2N

RT @GEFP_SEFH: Early administration of adalimumab for paediatric uveitis due to Behçet’s disease https://t.co/wzMz3g28sg

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease https://t.co/wzMz3g28sg